Pancreas Cancer Symposium 2020: Current and Future
Mar 20, 2020 7:30 AM
Pancreas adenocarcinoma is on the rise. Treatment paradigms are changing and many novel approaches are under development in this disease. This one day course in conjunction with the Center for Pancreas Cancer Research (CPCR) at Memorial Sloan Kettering (MSK) is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments and emerging directions.
The course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, nursing, advanced practice practitioners, trainees and other disciplines.
MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact email@example.com for more information.
Read more and register here